Gaweco AS et al. |
Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527948
|
Klintmalm GB et al. |
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679826
|
Fukuzawa M and Okada A |
Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection. |
1994 |
Transplant. Proc. |
pmid:7513483
|
Jordan ML et al. |
FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. |
1993 |
Transplant. Proc. |
pmid:7679827
|
Warty VS et al. |
Practical aspects of FK 506 analysis (Pittsburgh experience). |
1991 |
Transplant. Proc. |
pmid:1721259
|
Van Thiel DH et al. |
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689893
|
Jusko WJ and D'Ambrosio R |
Monitoring FK 506 concentrations in plasma and whole blood. |
1991 |
Transplant. Proc. |
pmid:1721260
|
Sher LS et al. |
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623212
|
Millis JM et al. |
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623213
|
Grewal HP et al. |
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636558
|
Tanabe K et al. |
Malabsorption of tacrolimus in kidney transplant recipients: a Japanese single center experience. |
2000 |
Transplant. Proc. |
pmid:11119906
|
Rossi G et al. |
Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience. |
1998 |
Transplant. Proc. |
pmid:9636562
|
Wong KM et al. |
Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study. |
2000 |
Transplant. Proc. |
pmid:11119907
|
Yao B et al. |
The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375298
|
Vilalta R et al. |
Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12644102
|
Ciancio G et al. |
Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12644172
|
Rath T and Küpper M |
Comparison of inosine-monophosphate-dehydrogenase activity in patients with enteric-coated mycophenolate sodium or mycophenolate mofetil after renal transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715967
|
Morell Ginestà M et al. |
Histology and immunopathology of heart and liver xenografts under low-dose tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959305
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus. |
2002 |
Transplant. Proc. |
pmid:11959335
|
McLachlan G et al. |
Growth inhibition of the MOLT-4 human T-leukemia cell line. A comparison of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721291
|
D'Silva M et al. |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623476
|
Thomas FT et al. |
Comparative efficacy of immunosuppressive drugs in xenografting. |
1990 |
Transplant. Proc. |
pmid:1693452
|
Lipson DA et al. |
Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation. |
1998 |
Transplant. Proc. |
pmid:9636612
|
Braun F et al. |
An ex vivo model to study the intestinal biotransformation of immunosuppressives. |
2000 |
Transplant. Proc. |
pmid:11120282
|
Vanrenterghem Y |
Vascular rejection with tacrolimus and potential long-term graft outcome. |
1999 |
Transplant. Proc. |
pmid:10576054
|
Iaria G et al. |
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. |
2010 |
Transplant. Proc. |
pmid:20534252
|
Woodle ES |
A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report. |
2005 |
Transplant. Proc. |
pmid:15848538
|
Akiyama T et al. |
Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan. |
2005 |
Transplant. Proc. |
pmid:15848551
|
López-Montenegro Soria MA et al. |
Genetic polymorphisms and individualized tacrolimus dosing. |
2010 |
Transplant. Proc. |
pmid:20970601
|
Andrés A et al. |
Extended-release tacrolimus therapy in de novo kidney transplant recipients: single-center experience. |
2010 |
Transplant. Proc. |
pmid:20970602
|
Nowacka-Cieciura E et al. |
Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249576
|
Yasutomi M et al. |
Mechanism of antibody production in hamster-to-rat concordant xenotransplantation: establishment of a simple model using intravenous injection of concordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518110
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Tze WJ et al. |
FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats. |
1992 |
Transplant. Proc. |
pmid:1376509
|
Rao PN et al. |
Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7682366
|
Armstrong VW et al. |
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533371
|
Ebbs A et al. |
Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. |
2002 |
Transplant. Proc. |
pmid:12176404
|
Jordan ML et al. |
Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium. |
1991 |
Transplant. Proc. |
pmid:1721323
|
Akioka K et al. |
Abdominal pain is a critical complication of mycophenolate mofetil in renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12591411
|
Hohage H et al. |
Differential effects of cyclosporine and tacrolimus on mycophenolate pharmacokinetics in patients with impaired kidney function. |
2005 |
Transplant. Proc. |
pmid:15919453
|
Borda B et al. |
Early histopathological changes in new-onset diabetes after kidney transplantation. |
|
Transplant. Proc. |
pmid:25131129
|
Laskow DA et al. |
Phase II FK 506 multicenter concentration control study: one-year follow-up. |
1995 |
Transplant. Proc. |
pmid:7533431
|
Shapiro R et al. |
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. |
1995 |
Transplant. Proc. |
pmid:7533432
|
Reyes J et al. |
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721355
|
Whiteside TL et al. |
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721356
|
Reis A et al. |
Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal transplantation. |
1998 |
Transplant. Proc. |
pmid:9865380
|
Emiroglu R et al. |
Tacrolimus-related neurologic and renal complications in liver transplantation: A single-center experience. |
2006 |
Transplant. Proc. |
pmid:16549190
|
Prates LC et al. |
Pain syndrome induced by calcineurin inhibitor and resolved by conversion to sirolimus in a child after kidney transplantation: a case report. |
2012 |
Transplant. Proc. |
pmid:23026634
|
Martin Garcia D et al. |
Tacrolimus-Basiliximab versus Cyclosporine-Basiliximab in renal transplantation "de novo": acute rejection and complications. |
2003 |
Transplant. Proc. |
pmid:12962761
|
Solà R et al. |
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine. |
2003 |
Transplant. Proc. |
pmid:12962763
|
Naraghi RM et al. |
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123013
|
Nishi K et al. |
The colon displays an absorptive capacity of tacrolimus. |
2004 |
Transplant. Proc. |
pmid:15050160
|
Velio P et al. |
Rejection and survival after total orthotopic liver-small bowel allotransplantation in pigs immunosuppressed with FK 506. |
1996 |
Transplant. Proc. |
pmid:8907936
|
Sonnenday CJ et al. |
Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. |
2002 |
Transplant. Proc. |
pmid:12176507
|
Bardella MT et al. |
FK 506 and cyclosporine: effect on D-xylose absorption in pigs with orthotopic liver-small bowel allotransplants. |
1996 |
Transplant. Proc. |
pmid:8907937
|
Ciancio G et al. |
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176508
|
Di Benedetto F et al. |
University of Modena experience in HIV-positive patients undergoing liver transplantation. |
2011 |
Transplant. Proc. |
pmid:21620066
|
Gringeri E et al. |
Neoadjuvant therapy protocol and liver transplantation in combination with pancreatoduodenectomy for the treatment of hilar cholangiocarcinoma occurring in a case of primary sclerosing cholangitis: case report with a more than 8-year disease-free survival. |
2011 |
Transplant. Proc. |
pmid:21620084
|
Matsuura T et al. |
Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation. |
1994 |
Transplant. Proc. |
pmid:7520616
|
Ota K |
Living donor kidney transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520622
|
Thomson AW et al. |
Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468203
|
Hossein-Nia M et al. |
Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721388
|
Rastellini C et al. |
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083278
|
Millis JM et al. |
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123421
|
Klupp J et al. |
New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus. |
2001 |
Transplant. Proc. |
pmid:11377491
|
Mollison KW et al. |
Discovery of FK 506 analogues that are nontoxic to mouse pancreatic beta cells in vitro but show diabetogenic potential when administered to the rat. |
1996 |
Transplant. Proc. |
pmid:8962236
|
Pozzetto U et al. |
Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176558
|
Mao PC et al. |
Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan. |
2012 |
Transplant. Proc. |
pmid:22310611
|
Tsai SF et al. |
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database. |
2012 |
Transplant. Proc. |
pmid:22310612
|
Markus PM et al. |
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721418
|
Yuzawa K et al. |
Topical immunosuppression in skin grafting with FK 506 ointment. |
1996 |
Transplant. Proc. |
pmid:8658707
|
Yagura K et al. |
Pharmacokinetic characteristics of two types of liposomal FK 506. |
1996 |
Transplant. Proc. |
pmid:8658708
|
Calconi G and Vianello A |
One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267173
|
Pretagostini R et al. |
Conversion from cyclosporin to tacrolimus in chronic allograft nephropathy. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267174
|
Dresske B et al. |
Synergistic impact of "WOFIE" on the immunosuppressive potency of FK 506 in a heterotopic heart transplantation model in the rat. |
1999 |
Transplant. Proc. |
pmid:10331001
|
Nayeri A et al. |
Acute Calcineurin Inhibitor Nephrotoxicity Secondary to Turmeric Intake: A Case Report. |
|
Transplant. Proc. |
pmid:28104136
|
Sicilia-Castro D et al. |
Reconstruction of a severe facial defect by allotransplantation in neurofibromatosis type 1: a case report. |
2011 |
Transplant. Proc. |
pmid:21911174
|
Dedhia P et al. |
Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case Report. |
|
Transplant. Proc. |
pmid:28104134
|
Kanatani T et al. |
Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival. |
2005 |
Transplant. Proc. |
pmid:15964421
|
Lang M et al. |
Combined liver-kidney transplantation: long-term follow-up in 18 patients. |
1998 |
Transplant. Proc. |
pmid:9723313
|
Gnatta D et al. |
Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study. |
2010 |
Transplant. Proc. |
pmid:20304169
|
Behr TM et al. |
Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A. |
1998 |
Transplant. Proc. |
pmid:9723333
|
Trotter JF |
Sirolimus in liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12742496
|
Ventura E et al. |
Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring. |
2009 |
Transplant. Proc. |
pmid:19328963
|
Ojogho ON et al. |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12176641
|
van der Laan LJ et al. |
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus. |
2010 |
Transplant. Proc. |
pmid:21168740
|
Gruttadauria S et al. |
A safe immunosuppressive protocol in adult-to-adult living related liver transplantation. |
2006 |
Transplant. Proc. |
pmid:16757278
|
Nanmoku K et al. |
Steroid Withdrawal Using Everolimus in ABO-Incompatible Kidney Transplant Recipients With Post-Transplant Diabetes Mellitus. |
2018 |
Transplant. Proc. |
pmid:29631750
|
Yumiba T et al. |
Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation. |
1995 |
Transplant. Proc. |
pmid:7540780
|
Langrehr JM et al. |
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267360
|
Nikolaidis NL et al. |
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. |
1991 |
Transplant. Proc. |
pmid:1721450
|
Ochiai T et al. |
Studies on FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450414
|
|
Immunosuppression: FK506. |
1988 |
Transplant. Proc. |
pmid:2450415
|
Chang HK et al. |
Ten-Year Experience With Bowel Transplantation at Seoul St. Mary's Hospital. |
2016 |
Transplant. Proc. |
pmid:27109981
|
González-Pinto I et al. |
Usefulness of the switch to tacrolimus in liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500653
|
Garcia CD et al. |
Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction. |
2002 |
Transplant. Proc. |
pmid:12431513
|
Wang M et al. |
Acute influence of FK506 on T-lymphocyte populations of peripheral blood and spleen in rats. |
2007 Jan-Feb |
Transplant. Proc. |
pmid:17275526
|
Fung JJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. |
1991 |
Transplant. Proc. |
pmid:1703682
|
Eghtesad B et al. |
Use of tacrolimus as the primary immunosuppression after renal transplant in Native Americans and Hispanics. |
1998 |
Transplant. Proc. |
pmid:9636500
|
Pichlmayr R et al. |
Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study. |
1997 |
Transplant. Proc. |
pmid:9270825
|